Glucagon-like peptide-1 (GLP-1) is a gut neuropeptide secreted by the distal small intestine in response to a meal.1 GLP-1 receptor agonists are existing therapeutic agents used in the treatment of diabetes. Here, GLP1R is linked to diabetes mellitus.